277 related articles for article (PubMed ID: 27044827)
21. The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.
Hao X; Wei X; Huang F; Wei Y; Zeng H; Xu L; Zhou Q; Feng R
PLoS One; 2015; 10(5):e0126615. PubMed ID: 25974110
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH
Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050
[TBL] [Abstract][Full Text] [Related]
23. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway.
Wang Y; Zhang M; Xu H; Wang Y; Li Z; Chang Y; Wang X; Fu X; Zhou Z; Yang S; Wang B; Shang Y
Oncotarget; 2017 Sep; 8(42):72182-72196. PubMed ID: 29069778
[TBL] [Abstract][Full Text] [Related]
24. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
Wu YY; Xing YR; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
[TBL] [Abstract][Full Text] [Related]
25. BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
Jovanovic MP; Mihaljevic B; Jakovic L; Martinovic VC; Fekete MD; Andjelic B; Antic D; Bogdanovic A; Boricic N; Terzic T; Jelicic J; Milenkovic S
J BUON; 2015; 20(3):820-8. PubMed ID: 26214636
[TBL] [Abstract][Full Text] [Related]
26. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma.
Cheng H; Yan Z; Wang X; Cao J; Chen W; Qi K; Zhou D; Xia J; Qi N; Li Z; Xu K
Mol Cell Biochem; 2019 Nov; 461(1-2):47-56. PubMed ID: 31338678
[TBL] [Abstract][Full Text] [Related]
28. Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.
Wang YF; Zhang S; Li XQ; Wang Y
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3987-3991. PubMed ID: 27775802
[TBL] [Abstract][Full Text] [Related]
29. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
Shi X; Cui Z; Liu X; Wu S; Wu Y; Fang F; Zhao H
Biochem Biophys Res Commun; 2019 Mar; 510(4):594-600. PubMed ID: 30739786
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
[TBL] [Abstract][Full Text] [Related]
31. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
Huang Y; Lin Y; Song X; Wu D
Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
[TBL] [Abstract][Full Text] [Related]
32. A 6-lncRNA signature predicts prognosis of diffuse large B-cell lymphoma.
Gao H; Wu B; Jin H; Yang W
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-12. PubMed ID: 33710713
[TBL] [Abstract][Full Text] [Related]
33. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
35. Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Qian Z; Chen L; Wang X; Kan Y; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Ge P; Ding T; Zhai Q; Zhao H
Clin Exp Med; 2022 May; 22(2):183-191. PubMed ID: 34427833
[TBL] [Abstract][Full Text] [Related]
36. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
Stefancikova L; Moulis M; Fabian P; Vasova I; Zedek F; Ravcukova B; Muzik J; Kuglik P; Vranova V; Falkova I; Hrabalkova R; Smardova J
Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA HULC regulates the NF-κB pathway and represents a promising prognostic biomarker in liver cancer.
Liu S; Huttad L; He G; He W; Liu C; Cai D; Chen H; Qiu J
Cancer Med; 2023 Feb; 12(4):5124-5136. PubMed ID: 36213936
[TBL] [Abstract][Full Text] [Related]
40. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
